HTI-5 remains a planning input, not a current certification requirement
The proposed rule points toward further certification, API, and information-blocking changes, but its provisions cannot be scored as final obligations.
Editorial figure by Health Interoperability Review. Source context: ASTP/Office of the National Coordinator for Health IT.
Scenario planning is different from compliance mapping
Product leaders should examine a proposed rule early enough to identify architecture, testing, policy, and contracting implications. They should also maintain a separate current-state register that includes only finalized and effective requirements.
Combining those registers creates predictable errors: proposals appear as obligations, product roadmaps are described as compliance, and buyers lose visibility into what could still change before a final rule.
A useful market record preserves uncertainty
Each proposed provision should have a source, date, affected workflow, current status, decision owner, and trigger for reassessment. When a final rule arrives, the record should show what was finalized, modified, delayed, or omitted rather than silently overwriting history.
Vendors should be evaluated on their ability to absorb standards change, not on claiming certainty about an unfinished rule. Release governance, versioning, test automation, and customer communication remain durable differentiators.
Enterprise buyer test
Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.
A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.
What we will watch next
Health Interoperability Review will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.